依达拉奉治疗急性脑出血33例疗效观察

Observation on edaravone for acute cerebral hemorrhage in 33 cases

目的:观察依达拉奉对急性期脑出血的治疗效果及安全性。方法:将64例急性期脑出血患者随机分为治疗组和对照组,治疗组在常规治疗(给予脱水降颅压、控制血压)的基础上,给予依达拉奉30mg加生理盐水100ml静滴,30分钟滴完,2次/日,共14天。采用脑卒中临床神经功能缺损程度评分量表进行评分和疗效评定。结果:治疗14天后治疗组临床疗效明显高于对照组(P<0.05)。治疗组显效率和有效率明显高于对照组。结论:早期应用依达拉奉可明显促进脑出血患者神经功能康复,提高疗效。

Objective:To observe edaravone on acute cerebral hemorrhage therapeutic effect and safety.Methods:64 patients with acute intracerebral hemorrhage were randomly divided into treatment group and control group,the treatment group were given conventional treatment of dehydration in reducing intracranial pressure,blood pressure control on the basis of given edaravone30mg intravenous infusion of normal saline 100ml,30 minutes drip finished,2times a day for 14 days.Using the fourth edition of the People's Health Publishing House Nan Dengkun editor of 'rehabilitation medicine' stroke clinical neurological deficit Rating Scale score and efficacy evaluation.Results:14 days after,the clinical efficacy of the treatment group was significantly higher(P<0.05).Treatment group was significantly higher efficiency and effectiveness.Conclusion:The early application of edaravone significantly facilitate the rehabilitation of neurological function in patients with cerebral hemorrhage and improve efficacy.